Zosano Pharma Corp Costs and Expenses
Zosano Pharma Corp reported Costs and Expenses of $33.45 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2022-05-13
- Zosano Pharma Corp costs and expenses for the quarter ending 2022-03-31 was $33.45M, a 302.72% increase year-over-year.
- Zosano Pharma Corp costs and expenses for the quarter ending 2021-12-31 was $7.00M, a 14.17% decline year-over-year.
- Zosano Pharma Corp costs and expenses for the quarter ending 2021-09-30 was $8.85M, a 3.74% increase year-over-year.
- Zosano Pharma Corp costs and expenses for the quarter ending 2021-06-30 was $8.16M, a 6.00% increase year-over-year.
- Zosano Pharma Corp costs and expenses for fiscal 2021 was $32.32M, a 2.02% decline from fiscal 2020.
- Zosano Pharma Corp costs and expenses for fiscal 2020 was $32.98M, a 11.33% decline from fiscal 2019.
- Zosano Pharma Corp costs and expenses for fiscal 2019 was $37.20M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2022-03-31 | $33.45M 10-Q · filed 2022-05-13 | $40.45M derived: sum of 2 quarters · filed 2022-05-13 | $49.30M derived: sum of 3 quarters · filed 2022-05-13 | $57.46M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $15.85M derived: sum of 2 quarters · filed 2022-03-17 | $24.01M derived: sum of 3 quarters · filed 2022-03-17 | $32.32M 10-K · filed 2022-03-17 |
| 2021-09-30 | $8.85M 10-Q · filed 2021-11-10 | $17.01M derived: sum of 2 quarters · filed 2021-11-10 | $25.31M 10-Q · filed 2021-11-10 | $33.47M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $8.16M 10-Q · filed 2021-08-10 | $16.47M 10-Q · filed 2021-08-10 | $24.63M derived: sum of 3 quarters · filed 2022-05-13 | $33.15M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $8.31M 10-Q · filed 2022-05-13 | $16.47M derived: sum of 2 quarters · filed 2022-05-13 | $24.99M derived: sum of 3 quarters · filed 2022-05-13 | $32.69M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $16.69M derived: sum of 2 quarters · filed 2022-03-17 | $24.39M derived: sum of 3 quarters · filed 2022-03-17 | $32.98M 10-K · filed 2022-03-17 |
| 2020-09-30 | $8.53M 10-Q · filed 2021-11-10 | $16.23M derived: sum of 2 quarters · filed 2021-11-10 | $24.82M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $7.70M 10-Q · filed 2021-08-10 | $16.29M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $8.60M 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $37.20M 10-K · filed 2021-03-11 |